Clinical and biological implications of driver mutations in myelodysplastic syndromes
Top Cited Papers
Open Access
- 21 November 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 122 (22) , 3616-3627
Abstract
Key Points: MDS is characterized by mutations in >40 genes, a complex structure of gene-gene interactions and extensive subclonal diversification. The total number of oncogenic mutations and early detection of subclonal mutations are significant prognostic variables in MDS.Keywords
This publication has 48 references indexed in Scilit:
- Clonal diversity of recurrently mutated genes in myelodysplastic syndromesLeukemia, 2013
- Recurrent SETBP1 mutations in atypical chronic myeloid leukemiaNature Genetics, 2012
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- The landscape of cancer genes and mutational processes in breast cancerNature, 2012
- The Life History of 21 Breast CancersCell, 2012
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingNature, 2012
- Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesNature Genetics, 2011
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromesLeukemia, 2011
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- The cancer genomeNature, 2009